BioMarin Pharmaceutical Inc.BMRNNASDAQ

Revenue (LTM)

$3.2B

+12.9% YoY

Net Income (LTM)

$349M

-18.3% YoY

Free Cash Flow

$725M

Revenue CAGR (5Y)

+14.9%

Marginsimproving

FCF$0.7B

Profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	1,846	2,096↑13.5%	2,419↑15.4%	2,854↑18.0%	3,221↑12.9%
Gross Profit	1,376	1,593↑15.8%	1,887↑18.5%	2,274↑20.5%	2,484↑9.3%
Operating Income	-82	161↑295.5%	186↑15.4%	484↑160.6%	533↑10.2%
Net Income	-64	142↑320.9%	168↑18.4%	427↑154.6%	349↓18.3%
EBITDA	47	265↑459.4%	307↑15.6%	651↑112.1%	573↓11.9%
EPS Diluted	-0.35	0.75↑314.3%	0.88↑17.3%	2.21↑151.1%	1.80↓18.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	587	725↑23.4%	755↑4.2%	943↑24.9%	1,312↑39.1%
Total Current Assets	2,274	2,751↑21.0%	2,956↑7.4%	3,232↑9.3%	3,953↑22.3%
Total Assets	6,005	6,375↑6.2%	6,842↑7.3%	6,989↑2.2%	7,594↑8.7%
Total Current Liabilities	546	589↑7.8%	1,177↑99.9%	607↓48.4%	759↑25.0%
Total Liabilities	1,739	1,772↑1.9%	1,890↑6.7%	1,331↓29.6%	1,507↑13.2%
Total Equity	4,266	4,603↑7.9%	4,952↑7.6%	5,658↑14.3%	6,087↑7.6%
Total Debt	1,090	1,093↑0.4%	1,096↑0.2%	649↓40.7%	643↓1.0%
Net Debt	502	369↓26.6%	341↓7.7%	-293↓186.1%	-669↓128.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	305	176↓42.2%	159↓9.5%	573↑259.7%	828↑44.5%
Capital Expenditure	-119	-121↓1.5%	-97↑20.1%	-97↓0.8%	-103↓5.8%
Free Cash Flow	185	55↓70.4%	63↑13.9%	475↑659.9%	725↑52.5%
Stock-Based Comp	197	196↓0.5%	207↑5.5%	202↓2.7%	181↓10.0%
Net Change in Cash	-62	137↑321.8%	31↓77.7%	188↑513.5%	369↑96.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance